Accurate Prediction of Peanut Allergy in One-Third of Adults Using a Validated Ara h 2 Cutoff
Open Access
- 1 April 2021
- journal article
- research article
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 9 (4) , 1667-1674.e3
Abstract
No abstract availableKeywords
Funding Information
- Teva Pharmaceutical Industries
- Thermo Fisher Scientific
- Universiteit Utrecht
- Gilead Sciences
This publication has 38 references indexed in Scilit:
- The diagnostic value of specific IgE to Ara h 2 to predict peanut allergy in children is comparable to a validated and updated diagnostic prediction modelJournal of Allergy and Clinical Immunology, 2013
- Validation of novel recipes for double-blind, placebo-controlled food challenges in children and adultsAllergy, 2011
- The non‐specific lipid transfer protein, Ara h 9, is an important allergen in peanutClinical & Experimental Allergy, 2009
- Nomenclature and structural biology of allergensJournal of Allergy and Clinical Immunology, 2007
- Does skin prick test reactivity to purified allergens correlate with clinical severity of peanut allergy?Clinical & Experimental Allergy, 2006
- Purification and immunoglobulin E‐binding properties of peanut allergen Ara h 6: evidence for cross‐reactivity with Ara h 2Clinical & Experimental Allergy, 2005
- Ara h 8, a Bet v 1–homologous allergen from peanut, is a major allergen in patients with combined birch pollen and peanut allergyJournal of Allergy and Clinical Immunology, 2004
- A consensus protocol for the determination of the threshold doses for allergenic foods: how much is too much?Clinical & Experimental Allergy, 2004
- Molecular cloning and epitope analysis of the peanut allergen Ara h 3Journal of Clinical Investigation, 1999
- Recombinant peanut allergen Ara h I expression and IgE binding in patients with peanut hypersensitivity.Journal of Clinical Investigation, 1995